Impel is a proud sponsor of the 2nd annual Mississippi Headache Symposium, bringing together providers and patients for a great educational event. You can meet us at our booth for more information on our migraine program. ...

Impel NeuroPharma will be attending the International Headache Congress (IHC) 2019 annual meeting. The team will present data from the INP104 clinical program. ...

The Impel team is attending the American Headache Society's (AHS) annual meeting. We will be presenting new data on our INP104 migraine program. ...

Dr. Greg Davis will be presenting on Impel's behalf at Rhinoworld 2019 in Chicago, IL on The Quantitative Scoring Scale - Nasal Mucosa (QSS-NM): A scale proposed for assessing olfactory mucosa changes following drug administration to the upper nasal space (olfactory epithelium) using a novel delivery device. For more information,...

Our CMO, Dr. Steve Shrewsbury, will be presenting the latest information on our THOR201 clinical study in Parkinson's disease at the World Parkinson's Congress in Kyoto, Japan. For more information, visit the event page here. ...

The Impel team is attending the American Society of Clinical Psychopharmacology 2019 annual meeting in Scottsdale, AZ. Jasna Hocevar-Trnka, M.D., M.P.H., will be presenting a talk on the results of our SNAP101 clinical study for INP105 (acute agitation). She will be presenting Tuesday May 28 at 3:45 PM. For more...

The Impel team is attending the American Psychiatric Association 2019 annual meeting in San Francisco, CA and will be presenting data on our first clinical study for our INP105 POD-Olanzapine program. For more information, visit the event page here. ...

The Impel team will attend the American Academy of Neurology 2019 annual meeting in Philadelphia, PA. Please come visit our booth to learn the latest information about out CNS therapeutics programs. We will also be presenting four posters on our latest research in migraine and Parkinson's. For more information, visit...

Impel's Director of Engineering, Christopher Fuller, will be presenting at the Nasal Drug Delivery Conference in London April 11-12. Presentation: Time: 2pm April 11th Duration: 40 min talkTitle: Developing next generation powder nasal delivery using POD technology Device development effortsFormulation development efforts Unique challenges to powder delivery...